CD24 and ductal breast carcinoma in situ: Overexpression of CD24 and CD44 have been correlated also to the malignant transformation and progression of BC, showing an increasing expression in invasive ductal carcinoma compared with ductal carcinoma in situ and intraductal hyperplasia, suggesting that these biomarkers might play an important role in BC development [34].